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Abstract
The interleukin-6 (IL-6) cytokine family plays an important role in regulating cellular responses during hematopoiesis. We report here that mice homozygous for a knock-in mutation in the IL-6 cytokine family receptor signaling subunit gp130 (gp130 Y757F/Y757F ) that leads to gp130-dependent STAT1/3 hyper-activation develop a broad spectrum of hematopoietic abnormalities, including splenomegaly, lymphadenopathy and thrombocytosis. To determine whether STAT3
hyper-activation was responsible for the perturbed hematopoiesis in gp130 Y757F/Y757F mice, we generated gp130 Y757F/Y757F mice on a Stat3 heterozygous (Stat3 :Stat3 +/-mice. Furthermore, we show that hematopoietic cells from gp130 Y757F/Y757F mice exhibited increased survival and proliferation in response to IL-6 family cytokines. Collectively, these data provide genetic evidence that gp130-dependent STAT3 hyperactivation during hematopoiesis has pathological consequences affecting multiple organs, and therefore identify the threshold of STAT3 signaling elicited by IL-6 family cytokines as a critical determinant for hematopoietic homeostasis.
Introduction
The interleukin (IL)-6 cytokine family, in particular IL-6, IL-11, oncostatin M (OSM) and leukemia inhibitory factor (LIF), exhibit both functional redundancy and pleiotropy in regulating proliferation, differentiation and functional maturation of cells belonging to multiple hematopoietic lineages. 1, 2 The importance of IL-6 family cytokines in regulating hematopoiesis in vivo has been demonstrated in mice by genetic modification of individual genes encoding members of this family, or their receptor subunits. For instance, mice lacking the common signaltransducing receptor β-subunit gp130 exhibit severely impaired fetal hematopoiesis, 3 and mice null for IL-6, LIF or the LIF receptor (LIFR) β-subunit display hematopoietic defects characterized by a reduction in the numbers of primitive hematopoietic progenitor cells. [4] [5] [6] Conversely, pathological consequences from the continuous activation of gp130 within the hematopoietic compartment have also been described, with mice over-expressing either LIF or both IL-6 and its soluble ligand-binding alpha subunit (sIL-6Rα) displaying hyper-proliferative abnormalities, including splenomegaly and thrombocytosis. 7, 8 Functional redundancy of the IL-6 cytokine family results from the use of the common receptor subunit gp130, 2 while the pleiotropic actions are associated with the coordinated and simultaneous activation of multiple signaling cascades which ultimately modulate gene expression and cellular responses. Ligand-induced gp130 homodimerization in response to IL-6
and IL-11, 9, 10 or heterodimerization of gp130 with either the LIFR 11 or OSMR 12 β-subunits in response to other IL-6 family cytokines, results in activation of Janus kinases (JAKs) and the subsequent tyrosine phosphorylation of the receptor cytoplasmic domain. 13 The four C-terminal phospho-tyrosine residues (pY) in murine gp130 serve as binding sites for signal transducers and activators of transcription (STAT) 1 and STAT3, 14 whereas the membrane-proximal pY 757 (pY 759 For personal use only. on . by guest www.bloodjournal.org From 4 in human gp130) facilitates binding of both suppressor of cytokine signaling (SOCS) 3 and the SH2 domain-containing tyrosine phosphatase SHP2, 15 the latter of which when phosphorylated also mediates activation of the Ras-mitogen activated protein kinase (MAPK) and PI3K
pathways. 16 It has recently been shown that the magnitude and duration of gp130-dependent signaling pathways are tightly coordinated by their reciprocal negative regulation. 17 For instance, while pY 757 is required for transduction of SHP2-mediated signaling, 18 it also enables negative regulation of gp130 signaling through the combined actions of the protein tyrosine phosphatase activity of SHP2, 19 and SOCS3 to down-modulate JAK activity and target the receptor complex for proteasomal degradation. 20 On the other hand, STAT3 activation induces expression of SOCS3 to create a negative feedback loop to terminate gp130-dependent signaling. 21 The latter mechanism has also been shown to be critical for G-CSF-mediated granulopoiesis in mice, where specific deletion of STAT3 in hematopoietic progenitors leads to neutrophilia due to the absence of G-CSFR/STAT3-dependent induction of SOCS3 to limit neutrophil production.
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The physiological importance of these negative regulatory mechanisms for gp130-dependent biological responses has been recently demonstrated by our laboratory 17 and others 23 through the generation of mice homozygous for knock-in mutations that abolish binding of specific signaling molecules to gp130. For instance, several abnormalities in gp130
mice, in which both SOCS3 and SHP2 are unable to bind to gp130, resemble those associated with continuous activation of gp130 in IL-6/sIL-6Rα or LIF transgenic mice, such as splenomegaly. 7, 8, 17 At the molecular level, the combined loss of SHP2 and SOCS3 binding to gp130 in gp130 Y757F/Y757F mice leads to exaggerated gp130-dependent STAT1 and STAT3 activation, which may account for, at least in part, the phenotype of these mice. 24 For personal use only. on January 30, 2018. by guest www.bloodjournal.org From 
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The activation of STAT3 is critical for the regulation of hematopoietic cell survival and proliferation, 22, 25, 26 and persistent STAT3 activation has also been observed in various haematological diseases, including myeloproliferative and lymphoproliferative disorders. 27 Our laboratory has previously demonstrated that gp130 ∆STAT/∆STAT mice unable to elicit gp130-dependent STAT1/3 activation display leukocytosis and thrombocytopenia, 28 Animals were housed under specific pathogen-free conditions.
For biochemical analyses, mice were subjected to a single intra-peritoneal injection with human (h) IL-6 (5µg).
Cytokines and antibodies
Recombinant murine (m) SCF was a kind gift from N. Nicola (Walter and Eliza 
Hematologic analyses
Blood from the retro-orbital plexus of mice was collected into EDTA-coated tubes and analysed on an Advia TM 120 System quantitative hematology analyser (Bayer Diagnostics). Manual differential cell counts were performed on May-Grunwald-Giemsa-stained blood smears and cytocentrifuge preparations of spleen and bone marrow single cell suspensions.
Hematopoietic progenitor cell assays
Clonal cultures of hematopoietic progenitor cells were assayed in semi-solid agar containing 0.3% agar, Dulbecco's modified Eagle's medium (DMEM) and 20% fetal bovine serum (FBS).
Briefly, triplicate cultures of cells from bone marrow (2.5 × 10 4 ) or spleen (2.5 × 10 5 ) were stimulated with SCF (50ng/ml) and IL-3 (10ng/ml). Cultures were incubated for 7 days at 37 0 C in a humidified atmosphere of 10% CO 2 in air. Colonies containing 50 or more cells were enumerated using a dissection microscope. Agar cultures were fixed with 2.5% glutaraldehyde and sequentially stained with acetylcholinesterase, Luxol Fast Blue and hematoxylin for determination of the composition of each colony by light microscopy. Megakaryocyte colonies were defined as those containing 3 or more megakaryocytes.
Colony-forming unit-spleen (CFU-S) assays
CFU-S assays were performed using 7. 
Histological analyses
Following dissection, spleen and femoral bone marrow specimens were fixed in 10% formalin solution and embedded in paraffin. Sections were stained with hematoxylin and eosin.
Megakaryocytes were enumerated by light microscopy under 200× (spleen) and 400× (bone marrow) magnification. A minimum of 30 microscopic fields was scored.
Protein extraction and immunoblot analysis
Lysates were prepared from snap-frozen cell pellets and tissues in ice-cold lysis buffer. 30 Lysates were cleared of debris by centrifugation, separated on 10% polyacrylamide gels and then transferred to nitrocellulose membranes. Membranes were blocked in TBST (300mM NaCl, 
RNA isolation and expression analysis
Total RNA was extracted from frozen cell pellets and tissue using TRIzol reagent (Invitrogen Life Technologies) according to the manufacturer's protocol. cDNA was prepared from 5µg of total RNA using the SuperScript III First-Strand Synthesis System (Invitrogen Life 
Cell viability and apoptosis assays
Bone marrow and spleen cells (5 × 10 6 ) were added to 6-well plates containing 2ml DMEM supplemented with 1% FBS with or without IL-6 (100ng/ml). After 5 days of culture at 37 o C, viable cell numbers were determined by exclusion of trypan blue dye. To measure apoptosis, cells were stained with FITC-labelled annexin-V and propidium iodide (PI) according to the manufacturer's protocol (R&D Systems), and flow cytometric analysis was performed.
Statistical analyses
Comparisons between mean values were performed using Anova and Student's t-tests as appropriate. A P value of less than 0.05 was considered statistically significant. Figure 1A ). While the hematocrit and total white blood cell count of gp130 Y757F/Y757F mice were comparable to those of , 2.14 ± 1.28 × 10 6 /ml, mean ± SD, P < 0.05; Figure 1D ). To discount the possibility these differences observed on a mixed 129 × C57BL/6
background were a function of strain differences, these experiments were repeated with mice back-crossed onto a C57BL/6 background over 10 generations. Similar magnitudes of differences were observed (data not shown), and data presented in the remainder of this study were generated from mice of all genotypes on a mixed 129 × C57BL/6 background.
Increased numbers of hematopoietic progenitor cells in gp130 Y757F/Y757F mice
To determine if the perturbed hematopoiesis in gp130 Y757F/Y757F mice resulted from aberrant production of immature and committed hematopoietic progenitors, we assessed the frequency and lineage commitment of hematopoietic progenitors from bone marrow and spleen of gp130 Y757F/Y757F mice in agar cultures containing SCF and IL-3. Indeed, the total number of Figure 1) . Surprisingly, the frequency of megakaryocyte progenitors (Mk-CFC) in gp130 Y757F/Y757F bone marrow was not increased. However, substantial increases in the frequency of Mk-CFCs, as well as myeloid CFCs, were observed in spleens of gp130 Y757F/Y757F mice, which corresponded to further increases in absolute numbers due to the increased gp130 Y757F/Y757F splenic cellularity ( Table 2 ).
The frequency of day 12 CFU-S progenitor cells, which represent immature multipotential hematopoietic progenitors, was increased in bone marrow and spleen of gp130
mice by approximately 2-fold and 5-fold, respectively, compared to gp130 +/+ littermates (Table   2 ). Furthermore, we observed a similar 2-fold increase in the absolute numbers of CFU-S :Stat3 +/-mice ( Figure 2B ). Figure 3A) .
Reduced gp130-dependent STAT3 activation in gp130
Similarly, the neutrophilia evident in gp130 Y757F/Y757F mice was absent in gp130 :Stat3 +/-mice were reduced from those observed in gp130 Y757F/Y757F mice back to wild-type levels ( Figure 5) .
Similarly, the total number of blast cell-CFCs, which represent the most immature progenitor cell detectable in clonogenic assays, was normal. The absolute number of splenic Mk-CFC was also normal in gp130
:Stat3 +/-mice ( Figure 5B ).
We next determined whether the abnormalities observed in lymphoid organs of :Stat3 +/-mice were only partially restored back to normal ( Figure 6C,D) . From these data, we conclude that removal of one Stat3 allele in gp130 Y757F/Y757F mice reduces gp130-dependent STAT3 activation to a level that leads to rescue of the myeloid and thrombopoietic abnormalities, as well as amelioration of the perturbed lymphopoiesis.
Enhanced survival and proliferation of gp130 Y757F/Y757F hematopoietic cells
Since STAT3 has been implicated as a crucial regulator of cell survival and proliferation, 22, 25, 26 we next examined whether these responses were enhanced in cultured gp130 hyper-activation as a consequence of impaired negative regulation of gp130 signaling. 17, 23 Indeed, the striking finding of our present study was that the thrombocytosis, splenomegaly and, to a lesser extent, lymphadenopathy in gp130 Y757F/Y757F mice were eliminated by genetically reducing the cellular pool of STAT3 protein and activity, thus identifying STAT3 hyperactivation, rather than loss of SHP2-MAPK activation, via gp130 as a major mechanism triggering the hematopoietic abnormalities. Furthermore, these abnormalities are intrinsic to the hematopoietic progenitors themselves, since wild-type mice reconstituted with bone marrow from gp130 Y757F/Y757F mice also displayed thrombocytosis and splenomegaly (data not shown).
The partial restoration of abnormalities in lymph nodes of gp130
:Stat3 +/-mice may be indicative of a STAT3 signal threshold requirement for homeostasis in this secondary lymphoid organ that is different to that in bone marrow, spleen and thymus.
Notably, our observations contrast those relating to the previously described gp130 For personal use only. on January 30, 2018. by guest www.bloodjournal.org From splenomegaly and lymphadenopathy. 23 It was reported that cell autonomous gp130-dependent signaling in gp130 F759/F759 mice was largely dispensable for hematopoiesis, since colony forming assays and reconstitution experiments using gp130 mutant fetal liver cells failed to identify any hematopoietic abnormalities. 23 As discussed previously, 24 it is likely that the more subtle hematopoietic phenotype of gp130 F759/F759 mice is a consequence of a STAT3 signal that is below the threshold enabling the hyper-responsiveness of hematopoietic progenitor cells that is observed in gp130 Y757F/Y757F mice.
With respect to the role of STAT3 during hematopoiesis, different strains of bone marrow-specific Stat3 null mice have been generated which display either neutrophilia 22 or an inflammatory disease in the gastro-intestinal tract. 26 While the variation in these phenotypes is the result of differences in the Mx 22 and Tie2 expression. 22 This notion was directly supported by a recent study in which hematopoieticspecific deletion of Socs3 in Socs3 -/∆Vav mice also resulted in neutrophilia and a complex inflammatory disease that was characterized by the hyper-responsiveness of myeloid cells to G-CSF, most likely as a consequence of exaggerated G-CSF-dependent STAT3 activation. 34 However, it was noted in this latter study that the pathology observed in older diseased Socs3 -/∆Vav mice was unlikely caused by dysregulated G-CSF signaling alone. In this respect, SOCS3-deficient macrophages from Socs3 -/∆LysM mice display increased IL-6-induced STAT3 activation and are also hyper-responsive to IL-6, 35 which is consistent with the emerging view that SOCS3
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is a critical physiological regulator of gp130-dependent signaling, and suggests that IL-6 family cytokines may contribute to disease development in conditional Socs3 -/∆Vav mice. Importantly, these mice develop hematopoietic abnormalities which strikingly resemble those observed in gp130 Y757F/Y757F mice reported here, including splenomegaly characterized by increased myelopoiesis and erythropoiesis, and increased myelopoiesis at the expense of erythropoiesis in the bone marrow. 34 Therefore, it is tempting to speculate that at least some of the shared pathologies between the conditional Socs3 -/∆Vav and gp130 Y757F/Y757F mice might be a consequence of increased STAT3 activation from IL-6 family cytokines. However, we cannot rule out the possibility that some of the abnormalities in gp130 Y757F/Y757F mice might be due to the observed increase in Socs3 expression which, although unable to negatively regulate signaling from the gp130(Y 757 F) receptor, may inappropriately trans down-modulate signaling from other cytokines affected by SOCS3 activity, such as G-CSF. 34 A mechanism highly sensitive to the extent of STAT3 signaling throughput in megakaryocytes and their progenitors is likely to play a crucial role in regulating platelet production. We have previously demonstrated that gp130 ∆STAT/∆STAT mice displayed mild thrombocytopenia caused by impaired IL-6 and IL-11 induced megakaryocyte maturation, suggesting that megakaryocyte maturation induced by IL-6 family cytokines is dependent upon STAT1/3 activation. 28 In contrast, the thrombocytosis in gp130 Y757F/Y757F mice resulted from increased numbers of megakaryocytes rather than enhanced megakaryocyte maturation, since the size of megakaryocytes in gp130 Y757F/Y757F bone marrow and spleen sections appeared normal (data not shown), an observation similar to that observed in thrombocytotic IL-6/sIL-6Rα or LIF transgenic mice. 7, 8 Previous studies have shown that long-term administration of IL-6 36 or IL-11 37, 38 to wild-type mice elevated in a dose-dependent manner the circulating platelet count which was associated with an increase in both megakaryocyte size (maturation) and number. Since we have observed a dose-dependent relationship between the amount of IL-6 or IL-11 administered and the extent of STAT3 phosphorylation in gp130 +/+ and gp130 Y757F/Y757F mice (data not shown),
we speculate that long-term treatment of wild-type mice with high doses of IL-6 family cytokines is likely to induce a stronger STAT3 signal than under "steady-state" conditions in IL-6/sIL-6Rα transgenic, LIF transgenic or gp130 Y757F/Y757F mice. Furthermore, the administration of exogenous IL-6 or IL-11 would then be likely to exceed the STAT3 signaling threshold required to promote both megakaryocyte production and maturation. Considering that the levels of circulating platelets in gp130 ∆STAT/∆STAT mice 28 (reduced), gp130 Y757F/Y757F mice (elevated), and Firstly, they restrict alterations to the throughput of a widely used signaling cascade (e.g. STAT3)
to a specific receptor, and secondly, they enable the investigation of its global requirement rather than limiting it by conditional gene modification to a predetermined temporal or spatial cellular compartment. This latter point is particularly pertinent to variations in the phenotype of existing conditional knock-out mouse models examining the role of STAT3 in hematopoiesis, which have predominantly focussed on the regulation of myelopoiesis by STAT3 as a consequence of STAT3 deletion being restricted to the bone marrow compartment. 22, 26 Finally, the wide availability of mice with null alleles for many components of the gp130 signaling network will enable the further genetic dissection of molecular mechanisms up-stream and down-stream of the gp130 receptor subunit which ultimately restrict the extensive pleiotropic activities of this For personal use only. on January 30, 2018. by guest www.bloodjournal.org From
